Abstract
The use of octadecasilyl silica and other resin columns (C18-, C8-, CN-, and phenyl resin) in the batch extraction of tissue homogenates provides a simple means of rapid purification of peptides from tissues or plasma. High acidity (5% formic acid, 1% trifluoroacetic acid, or 1 N HCl) inhibits the peptidase activity present in tissue. Immediate freezing and homogenization in cold dilute acid (pH 2) could preserve physiologically active peptides and inhibit the artificial generation of components. Polypropylene tubes, pipettes, and tips are more useful because many peptides are adsorbed to glass surface. Proteins with molecular weight greater than 40,000 are usually excluded by 6 to 10 nm pore of commercial resin. The high resolution of the separation technique is enhanced by using acidic solvent systems. At low pH, the absorption of peptides to the silica matrix is reduced, and column efficiency, in terms of peak shape and theoretical plates, is improved. In addition, hydrophobic and ion repairing agents, such as trifluoroacetic acid, are used to associate with the free amino groups, which become fully ionized at low pH. This increased affinity for the reverse phase support material permits separation of melanocyte stimulating hormone, melanocyte stimulating hormone, ACTH, calcitonin, cytochrome c, bovine serum albumin, bovine prolactin, and bovine growth hormones from brain tissue by a linear gradient of 20% to 60% acetonitrile containing 0.1% trifluoroacetic acid during a period of 2 hours. The solvent system also permits monitoring for ultraviolet light absorbance at 210 nm. Because of the volatility of the solvent, further separation and the processing of the biologically active peptide and evaluation by radioimmunoassay are possible.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Heldin, C.-H. and Westermark, B. , Growth factors: mechanism of action and relation to oncogenes, Cell,37, 9, 1984.
Todaro, G. J., De Larco, J. E. , and Fryling, C. M. , Sarcoma growth factor and other transforming peptides produced by human cells: interactions with membrane receptors, Fed Proc, 41, 2996, 1982.
Moses, H. L. , Branum, E. L. , Proper, J. A., and Robinson, R. A., Transforming growth factor production by chemically transformed cells, Cancer Res, 41, 2842, 1981.
Moses, H. L. , Childs, C. B., Halper, J., Shipley, G. D., and Tucker, R. F. , Role of transforming growth factors in neoplastic transformation, in Control of Cell Growth and Proliferation, Veneziale,C. M. , Ed., Van Nostrand Reinhold, New York, 1985, 147.
Holley, R. W. , Böhlen, P., Fava, R. , Baldwin, J. H., Kleeman, G., and Armour, R. , Purification of kidney epithelial cell growth inhibitors, Proc Natl Acad Sci USA. 77, 5989, 1980.
Holley, R. W. , Armour, R. , Baldwin, J. H. , and Greenfield, S., Preparation and properties of a growth inhibitor produced by kidney epithelial cells, Cell Biol Int Rep, 7, 525, 1983.
Holley, R. W. , Armour, R. , Baldwin, J. H. , and Greenfield, S., Activity of a kidney epithelial cell growth inhibitor on lung and mammary cells, Cell Biol Int Rep, 7, 141, 1983.
Carpenter, G. and Cohen, S., 125I-labeled human epidermal growth factor: binding, internalization and degradation in human fibroblasts, J Cell Biol, 71, 159, 1976.
Fox, C. F., Linsley, P. S., and Wrann, M., Receptor remodeling and regulation in the action of epidermal growth factor, Fed Proc, 41, 2988, 1982.
Reddi, A. H. , Extracellular matrix and development, in Extracellular Matrix Biochemistry, Piez, K. A. and Reddi, A. H. , Eds., Elsevier, New York, 1984, 375.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Dewanjee, M.K. (1992). Radioiodinated Peptides and Growth Factors and Their Applications. In: Radioiodination: Theory, Practice, and Biomedical Applications. Developments in Nuclear Medicine, vol 21. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3508-9_14
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3508-9_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6556-3
Online ISBN: 978-1-4615-3508-9
eBook Packages: Springer Book Archive